A recent study by Schafer et al. [94] found a relatively low frequency (1.3%) of mutation in another histone methyltransferase EZH2 in ALL, similar to low EZH2 mutation prevalence in ALL seen previously [50]. This evidence concerns the gene PRDM9 and acute lymphoblastic leukemia.